![]() |
市場調查報告書
商品編碼
2091619
息肉切片檢查市場規模、佔有率和成長分析:按產品、類型、應用、最終用戶和地區分類-2026-2033年產業預測Polyp Biopsy Market Size, Share, and Growth Analysis, By Product (Instruments, Kits and Consumables), By Type (Forceps Biopsy, Snare Biopsy), By Application, By End User, By Region - Industry Forecast 2026-2033 |
||||||
2024 年全球息肉切片檢查市場價值為 259 億美元,預計到 2033 年將從 2025 年的 279.2 億美元成長至 609.2 億美元,預測期(2026-2033 年)的複合年成長率為 7.81%。
全球息肉切片檢查市場涵蓋了用於切除和分析胃腸道息肉的關鍵設備和服務,隨著結直腸癌發病率的上升和篩檢計畫在重點地區的擴展,息肉活體組織切片在癌症早期發現中發揮著至關重要的作用。內視鏡黏膜下剝離術 (ESD) 試劑盒的引入革新了傳統方法,提高了組織取樣的準確性,減少了漏診,促使醫院升級其內視鏡設備。市場成長的關鍵促進因素之一是將人工智慧 (AI) 整合到內視鏡成像技術中,這提高了息肉檢測的準確性,並實現了標靶切片檢查。 AI 對可疑病變的即時識別使得在影像引導下及時進行組織取樣成為可能,從而提高了診斷準確性。採用 AI 驅動的手術流程提高了營運效率,增強了保險公司對保險覆蓋範圍的信心,並最終推動了市場擴張。
全球息肉切片檢查市場的成長要素
將人工智慧整合到內視鏡系統中,可顯著提高即時息肉檢測的準確性,並簡化切片檢查決策流程。這項進展不僅鼓勵臨床醫生進行更徹底的切片檢查,還能最大限度地減少操作過程中的不確定性,縮短新用戶的培訓時間,從而增強他們獲取有效診斷活體組織切片樣本的信心。因此,醫療機構和門診部越來越熱衷於投資人工智慧平台。這一趨勢是推動不同醫療機構對各種切片檢查設備和耗材需求成長的主要動力,並有助於改善患者預後。
全球息肉切片檢查市場的限制因素
全球息肉切片檢查市場面臨一項重大挑戰:監管批准的延遲導致新型切片檢查設備的上市時間延長。這些漫長的核准流程需要提供全面的安全性和有效性證明文件,阻礙了產品的及時上市。醫療機構通常會在獲得必要的監管批准後才做出採購決定,這會對當前的市場需求產生負面影響。這種不確定性使得製造商更難進行銷售預測,並可能阻礙整體市場成長。此外,核准的不確定性可能會抑制中小企業對利基技術的投資,從而限制市場的多樣性和創新。
全球息肉切片檢查市場趨勢
全球息肉切片檢查市場正呈現出微創技術日益普及的趨勢,促使人們更加關注能夠增強成像能力的先進內視鏡系統。這種轉變推動了對兼顧病患舒適度和高效組織取樣的息肉切片檢查器械的需求。製造商正透過設計更小巧、更易於使用的活體組織切片鉗和勒除器進行創新,從而縮短手術時間,並加快門診治療。這些進步不僅旨在減少住院時間和降低醫療成本,而且符合提高醫療效率和最佳化患者預後的更廣泛醫療目標,最終將徹底改變息肉的診斷方式。
Global Polyp Biopsy Market size was valued at USD 25.9 Billion in 2024 and is poised to grow from USD 27.92 Billion in 2025 to USD 60.92 Billion by 2033, growing at a CAGR of 7.81% during the forecast period (2026-2033).
The global polyp biopsy market is centered around devices and services integral to the extraction and analysis of gastrointestinal polyps, crucial for early cancer detection amidst rising colorectal cancer rates and expanding screening programs in key regions. Traditional methods have evolved with the introduction of endoscopic submucosal dissection kits, facilitating enhanced tissue sampling and reducing missed lesions, prompting hospitals to upgrade their endoscopy facilities. A significant driver of market growth is the integration of artificial intelligence in endoscopic imaging, which boosts polyp detection and guides targeted biopsies. Real-time AI identification of suspicious lesions allows for timely, image-guided sampling, improving diagnostic yield. Adoption of AI-enhanced procedures has led to better operational efficiency, increasing confidence in reimbursement coverage from insurance companies, thus fueling market expansion.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Polyp Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Polyp Biopsy Market Segments Analysis
Global polyp biopsy market is segmented by product, type, application, end user and region. Based on product, the market is segmented into instruments, kits and consumables and services. Based on type, the market is segmented into forceps biopsy, snare biopsy and brush biopsy. Based on application, the market is segmented into colorectal polyps, gastric polyps and nasal polyps. Based on end user, the market is segmented into hospitals, ambulatory surgical centers and diagnostic laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Polyp Biopsy Market
The incorporation of artificial intelligence into endoscopic systems significantly boosts the accuracy of real-time polyp detection and simplifies the decision-making process for biopsies. This advancement not only encourages clinicians to implement more thorough sampling practices but also minimizes procedural uncertainties and shortens the learning curve for new users, thereby enhancing their confidence in acquiring diagnostically pertinent tissue. As a result, healthcare institutions and outpatient facilities are increasingly motivated to invest in AI-powered platforms. This trend is a key driver for the growing demand for various biopsy equipment and consumables across diverse healthcare settings, facilitating improved patient outcomes.
Restraints in the Global Polyp Biopsy Market
The Global Polyp Biopsy market faces significant challenges due to delays in regulatory approvals, which extend the timelines for introducing new biopsy devices. These prolonged review processes necessitate comprehensive documentation related to safety and efficacy, subsequently hindering timely product launches. As healthcare providers often postpone purchasing decisions until products receive necessary regulatory endorsements, immediate demand is negatively impacted. This unpredictability makes revenue forecasting for manufacturers more challenging, potentially stifling overall market expansion. Furthermore, the uncertainty surrounding approvals can deter smaller companies from investing in niche technologies, thereby limiting the diversity and innovation within the market.
Market Trends of the Global Polyp Biopsy Market
The global polyp biopsy market is witnessing a significant trend towards the adoption of minimally invasive technologies, with an increasing emphasis on advanced endoscopic systems that enhance imaging and diagnostic capabilities. This shift is fostering heightened demand for polyp biopsy instruments that prioritize patient comfort and efficient tissue collection. Manufacturers are innovating by designing smaller, more user-friendly forceps and snares, enabling quicker procedures and promoting outpatient care. Such advancements not only aim to reduce hospitalization times and costs but also align with the healthcare sector's overarching goals of enhancing productivity and optimizing patient outcomes, ultimately reshaping the landscape of polyp diagnostics.